Diagnostic imaging for acute ischemic stroke management

Expert Review of Medical Devices

Volumn 3, Issue 1, 2006, Pages 113-126

  Jüttler, Eric ^a   Fiebach, Jochen B ^b   Schellinger, Peter D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Advanced CT; Cerebral ischemia; Imaging; Stroke MRI; Thrombolysis

Indexed keywords

[1,2,3,4 TETRAHYDRO 7 (1H IMIDAZOL 1 YL) 6 NITRO 2,3 DIOXO 1 QUINOXALINYL]ACETIC ACID; ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; AMPA RECEPTOR ANTAGONIST; AX 200; DESMOTEPLASE; EPTIFIBATIDE; FIBRINOLYTIC AGENT; GLUTAMATE RECEPTOR ANTAGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; PLASMINOGEN ACTIVATOR; TIROFIBAN; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANALYTIC METHOD; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; EMBOLECTOMY; HUMAN; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PATIENT INFORMATION; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; ANGIOGRAPHY; ANIMAL; COMPARATIVE STUDY; METHODOLOGY; RADIOGRAPHY;

ANGIOGRAPHY; ANIMALS; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644838368     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.1.113     Document Type: Review

References (88)

1. WHO Task Force on Stroke. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other cerebrovascular disorders. Stroke 20(10), 1407-1431 (1989).
2. Hacke W Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53(7), S3-Sl4 (1999).
3. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363(9411), 768-774 (2004).
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333(24), 1581-1587 (1995).
5. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review) The Cochrane Library (2) (2000). Update in: Cochrane Database Syst. Rev (3), CDO00213 (2003).
6. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29(l), 4-11 (1988).
7. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. J. Am. Med. Affoc. 282(21), 2003-2011 (1999).
8. Haley EC Jr, Brott TG, Sheppard GL et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke 24 (7), 1000-1004 (1993).
9. Fisher M, Albers GW Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology 52(9), 1750-1756 (1999).
10. Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology 54(8), 1548-1549 (2000).
11. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34 (2), 575-583 (2003).
12. Schramm P, Schellinger PD, Fiebach JB et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 h after onset. Stroke 33 (10), 2426-2432(2002).
13. Schramm P, Schellinger PD, Klotz E et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 h' duration. Stroke 35 (7), 1652-1658(2004).
14. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36(4), 557-565 (1994).
15. Astrup J, Siesjö B, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12(6), 723-725 (1981).
16. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke - a review. Part I - intravenous thrombolysis. Crit. CareMed. 29(9), 1812-1818 (2001).
17. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W. Thrombolytic therapy for ischemic stroke a review. Part II - intra-arterial thrombolysis, vertebrobasilar stroke, Phase IV trials, and stroke imaging. Crit. Care Med. 29(9), 1819-1825 (2001).
18. Schellinger PD, Jansen O, Fiebach JB, Hacke W. Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke 30(4), 765-768 (1999).
19. Crain MR, Yuh WTC, Greene GM et al. Cerebral ischemia: evaluation with contrast enhanced MR imaging. Am. J. Neuroradiol. 12(4), 631-639 (1991).
20. Shimosegawa E, Inugami A, Okedura T et al. Embolic cerebral infarction: MR findings in the first 3 h after onset. Am. J. Roentgenol. 160(5), 1077-1082 (1993).
21. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged <3 h and treated with recombinant tissue plasminogen activator. Am. J. Neuroradiol. 26(3), 618-624 (2005).
22. Evans M, Richradson DB, Tien R et al. Poststenotic signal loss in MR angiography: effects of echo time, flow compensation, and fractional echo. Am. J. Neuroradiol. 14(3), 721-729 (1993).
23. Fujita N, Hirabuki N, Fujii K et al. MR imaging of the middle cerebral artery stenosis and occlusion: value of MR angiography. Am. J. Neuroradiol, 15 (2), 335-341 (1994).
24. Yang JJ, Hill MD, Morrish WF et al. Comparison of pre- and postcontrast 3D time-of-flight MR angiography for the evaluation of distal intracranial branch occlusions in acute ischemic stroke. Am. J. Neuroradiol. 23(4), 557-567 (2002).
25. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161(2), 401-407 (1986).
26. Stadnik TW, Demaerel P, Luypaert RR et al. Imaging tutorial: differential diagnosis of bright lesions on diffusion-weighted MR images. Radiographics 23(1), E7 (2003).
27. Szabo K, Poepel A, Pohlmann-Eden B et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 128(6), 1369-1376 (2005).
28. Geijer B, Lindgren A, Brockstedt S, Stahlberg F, Holtas S. Persistent high signal on diffusion-weighted MRI in the late stages of small cortical and lacunar ischaemic lesions. Neuroradiology 43(2), 115-122 (2001).
29. Ay H, Buonanno FS, Rordorf G et al. Normal diffusion-weighted MRI during stroke-like deficits. Neurology 52(9), 1784-1792 (1999).
30. Fiebach JB, Jansen O, Schellinger PD, Heiland S, Hacke W, Sartor K. Serial analysis of the apparent diffusion coefficient time course in human stroke Neuroradiology 44(4), 294-298 (2002).
31. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion Imaging with NMR contrast agents. Magn. Reson. Med. 14 (2), 249-265 (1990).
32. Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion and perfusion MR1. Neurology 53(7), 1528-1537 (1999).
33. Baird AE, Lovblad KO, Dashe JF et al. Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke. Cervbraovasc. Dis. 10(6), 441-448 (2000).
34. Schellinger PD, Fiebach A Jansen O et al. Stroke magnetic resonance imaging within 6 h after onset of hyperacute cerebral ischemia. Ann. Neurol. 49 (4), 460-469 (2001).
35. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurements of tissue blood flow with intravascular tracers: which mean transit time? Magn, Reson. Med. 29(4), 553-559 (1993).
36. Jansen O, Schellinger F, Fiebach JB, Hacke W, Sartor K. Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI. Lancet 353(9169), 2036-2037 (1999).
37. Coutts SB, Simon JE, Tomanek AI et al. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke 34 (7), 1681-1683 (2003).
38. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal resonance imaging. Stroke 34 (11), 49 2729-2735(2003).
39. Schellinger PD, Jansen O, Fiebach JB et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. Am. J. Neuroradiol. 21(7), 1184-1189 (2000).
40. von Kummer R, Allen KL, Holle R et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 205(2), 327-333 (1997).
41. Provenzale JM, Jahan R, Naidich TP, Fox AJ. Assessment of the patient with hyperacute stroke: imaging and therapy. Radiology 229(2), 347-359 (2003).
42. Fiebach JB, Scheltinger PD, Jansen O et al. CT and diffusion-weighted MR-Imaging in randomized order: DWI results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33(9), 2206-2210 (2002).
43. von Kummer R, Bourquain H, Bastianello S et al. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 219(1), 95-100 (2001).
44. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355 (9216), 1670-1674(2000),
45. Knauth M, von Kummer R, Jansen O, Haehnel S, Doerfler A, Sartor K. Potential of CT angiography in acute isrhemic stroke. Am. J Neuroradiol. 18 (6), 1001 - 1010 (1997).
46. Shrier DA, Tanaka H, Numaguchi Y, Konno S, Patel U, Shibata D. CT angiography in the evaluation of acute stroke. Am. J Neuroradiol. 18(6), 1011-1020 (1997).
47. Koenig M, Kraus M, Theek C, Klotz E, Gehlen W, Heuser L. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 32(2), 431-437 (2001).
48. Wildermuth S, Knauth M, Brandt T, Winter R, Sartor K, Hacke W. Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 29(5), 935-938 (1998).
49. Koenig M, Klotz E, Luka B, Venderink DJ, Spittler JF, Heuser L. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology 209(1), 85-93 (1998).
50. Lev MH, Segal AZ, Farkas J et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final irifarct volume and clinical outcome. Stroke 32 (9), 2021-2028 (2001).
51. von Kummer R. Imaging of stroke pathology without predefined gold standard. Cerebrovasc. Dis. 14(3-4), 270 (2002).
52. Handschu. R, Garling A, Heuschmann PU, Kolominsky-Rabas PL, Erbguth F, Neundorfer B. Acute stroke management in the local general hospital. Stroke 32 (4), 866-870 (2001).
53. Powers WJ, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time. Neurology 50(4), 842-843 (1998).
54. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke 31(11), 2597-2602 (2000).
55. Jaeger HR. Diagnosis of stroke with advanced CT and MR imaging. Br. Med. Bull. 56(2), 318-333 (2000).
56. Weingarten K, Zimmerman RD, Cahill PT, Deck MD. Detection of acute intracerebral hemorrhage on MR imaging: ineffectiveness of prolonged interecho interval pulse sequences. Am. J. Neuroradiol. 12(3), 475-479 (1991).
57. Linfante I, Llinas RH, Caplan LR, Warach S. MRI features of intracerebral hemorrhage within 2 h from symptom onset. Stroke 30(11), 2263-2267 (1999).
58. Patel MR, Edelman RR, Warach S. Detection of hyperacute primary intraparenchymal hemorrhage by magnetic resonance imaging. Stroke 27 (12), 2321-2324 (1996).
59. Fiebach A Schellinger PD, Gass A et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging. Stroke 35 (2), 502-507 (2004).
60. Kidwell CS, Chelala JA, Saver JL et al. Comparison of MRI and CT detection of acute intracerebral hemorrhage. J. Am. Med. Assoc. 292(15), 1823-1830 (2004).
61. Steinbrich W, Gross-Fengels W, Krestin GP, Heindel W, Schreier W. Intracranial hemorrhages in the magnetic resonance tomogram. Studies on sensitivity, on the development of hematomas and on the determination of the cause of the hemorrhage. Rofo. Fortschr. Geb. Rontgenstr. Neuen Bildgeb. Verfahr. 152(5), 534-543 (1990).
62. Barber PA, Darby DG, Desmond PM et al. Identification of major ischemic change - diffusion-weighted imaging versus computed tomography. Stroke 30(10), 2059-2065 (1999).
63. Buckley BT, Wainwright A, Meagher T, Briley D. Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for inpatients with clinically suspected acute stroke. Clin. Radiol. 58(3), 234-237 (2003).
64. Lansberg MG, Albers GW, Beaulieu C, Marks MR Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 54(8), 1557-1561 (2000).
65. Saur D, Kucinski T, Grzyska U et al. Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke. Am. J. Neuroradiol. 24(5), 878-885(2003).
66. Kidwell CS, Alger JR, Di Salle F et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 30(6), 1174-1180 (1999).
67. Fiebach JB, Jansen O, Schellinger PD et al. Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke. Neuroradiology 43(8), 628-632 (2001).
68. Pexman JH, Hill MD, Buchan AM et al Hyperacute stroke: experience essential when reading unenhanced CT scans. Am. J. Neuroradiol. 25(3), 516-518 (2004).
69. Hjort N, Butcher K, Davis SM et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36(2), 388-397 (2005).
70. Derex L, Nighoghossian N, Hermier M et al. Thrombolysis for ischernic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc. Dis. 17(2-3), 238-241 (2004).
71. Demchuk AM, Hili MD, Barber PA et al. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36(10), 2110-2115 (2005).
72. Patel SC, Levine SR, Tilley BC et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. J. Am. Med. Assoc. 286(22), 2830-2838 (2001).
73. Bozzao L, Angeloni U, Bastianello S et al. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. Am. J. Neuroradiol. 12(6), 1115-1121 (1991).
74. von Kummer R, Bozzao L, Manelfe C. Early CT Diagnosis of Hemispheric Brain Infarction. Springer Verlag, Berlin, Germany, 1-95 (1995).
75. Fink JN, Kumar S, Horkan C et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 33(4) 988-993 (2002).
76. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56(8), 1015-1020 (2001).
77. O'Connor RE, McGraw R Edelson L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann. Emerg. Med. 33(1), 9-14 (1999).
78. Darby DG, Barber PA, Gerraty RP et al, Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30 (10), 2043-2052(1999).
79. Roether J, Schellinger PD, Gass A et al. Effect of thrombolysis on MRI parameters and functional outcome in acute stroke <6h. Stroke 33(10), 2438-2445 (2002).
80. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56(4), 468-477 (2004).
81. Nighoghossian N, Hermier M, Adeleine P et al. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke 33(3), 735-742 (2002).
82. Tsushima Y, Aoki J, Endo K. Brain microhemorrhages detected on T2*- weighted gradient-echo MR images. Am. J. Neuroradiol. 24(1), 88-96 (2003).
83. Derex L, Hermier M, Adeleine P et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J. Neurol. Neurosurg Psychiatry 76(1), 70-75 (2005).
84. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (1), 66-73 (2005).
85. Fiehler J, Fiebach JB, Gass A et al. Diffusion-weighted imaging in acute stroke - a tool of uncertain value? Cerebrovasc. Dis. 14(3-4), 187-196 (2002).
86. Shih LC, Saver JL, Alger JR et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 34(6), 1425-1430 (2003).
87. Yamada K, Wu O, Gonzalez RG et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 33(1), 87-94 (2002).
88. Dornnan GÅ, Davis SM. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol. 1(7), 417-425 (2002).